Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 381 participants.
Also called NCT02817776
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 381 participants
- Sponsor
- Registry
-
NCT02817776
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02817776. Allocation not applicable; no masking; primary purpose treatment. Start 2016-06-01 (actual); primary completion 2019-06-05 (actual). Results posted on 2021-01-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF)
- Acronym
- PRECEPT
- Condition
- Atrial Fibrillation
- Intervention (Device)
- THERMOCOOL SMARTTOUCH® SF catheter
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct02817776- Content hash
52d0399b493b8c0fef15ca939cd9a65731a9d54cad2d299f5711bd9e8c4e2b58